1. US Food and Drug Administration Guidance for Industry - Drug Interaction Studies: Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM292362.pdf 2012
2. US Food and Drug Administration Reviewer Guidance - Evaluating the Risks of Drug Exposure in Human Pregnancies. http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm071645.pdf 2005
3. U.S. Selected Practice Recommendations for Contraceptive Use, 2013. Adapted from the World Health Organization Selected Practice Recommendations for Contraceptive Use, 2nd Edition;Centers for Disease Control and Prevention;MMWR,2013
4. Update on overall prevalence of major birth defects-atlanta, Georgia 1978-2005;Centers for Disease Control and Prevention;MMWR Weekly,2008
5. European Medicines Agency Guideline on the Investigation of Drug Interactions http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/07/WC500129606.pdf 2012